查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1927707

全球霉浆菌检测市场：依产品类型、技术、检测类型、应用、国家及地区划分－产业分析、市场规模、份额及预测（2025-2032年）

Mycoplasma Testing Market, By Product Type, By Technology, By Test Type, By Application, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 387 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2024 年，霉浆菌检测市场规模将达到 14.5254 亿美元，从 2025 年到 2032 年，复合年增长率将达到 12.01%。

霉浆菌检测用于检测和定量细胞培养、生物製药和药物中的霉浆菌污染，以确保产品安全性并符合监管标准。对生物製药、疫苗和细胞疗法日益增长的需求正在推动研发和生产实验室采用霉浆菌检测解决方案。快速、灵敏的检测方法和自动化检测平台的发展具有巨大的潜力，它们可以缩短检测时间并提高检测准确性，对于大规模生物製药生产的品质控制至关重要。一个显着的趋势是将分子和PCR技术与传统培养方法结合，以提高检测可靠性并最大限度地减少假阴性结果。然而，霉浆菌检测的复杂性和检测灵敏度的差异性带来了挑战，限制了其在小规模实验室和需要超快速、高通量检测的应用中的使用。

霉浆菌检测市场动态

生物製药和细胞治疗生产中对污染控制的需求日益增长

生物製药、疫苗和细胞疗法的日益普及推动了对霉浆菌检测解决方案的显着需求。霉浆菌检测在确保这些产品的安全性、品质和合规性方面发挥着至关重要的作用。随着生物製药和治疗性细胞株生产的扩大，迫切需要快速可靠的霉浆菌检测方法来防止可能损害产品疗效和病人安全的污染。高通量、自动化检测平台的发展趋势进一步增加了需求，因为它们能够提供更快的检测结果、更稳定的准确性，并能整合到现代生物製造工作流程中。此外，全球生物製药生产的持续成长，尤其是在北美和欧洲等地区，也显着推动了对灵敏且标准化的霉浆菌检测的需求。例如，根据最新的2024年数据，超过75%的生物製药生产商将对所有细胞生产线进行常规霉浆菌检测。基因和细胞疗法的日益普及也推动了对强有力的污染监测的需求，以维持严格的品质标准。

霉浆菌检测市场：細項分析

全球霉浆菌检测市场按产品类型、技术、检测类型、应用和地区进行细分。

根据产品类型，市场可分为三大类：霉浆菌检测试剂盒、试剂和检测方法以及参考标准品。这些试剂盒提供快速、标准化且经过验证的解决方案，可减少检验流程的时间和人力投入。试剂和检测方法排名第二。它们对于客製化检测通讯协定至关重要，支援手动和自动化检测平台，并为基于分子和培养的检测方法提供高灵敏度和特异性。参考标准品紧随其后，提供关键的品管和校准材料，以确保检测的准确性、符合法规要求以及实验室间的可重复性。整体而言，市场优先顺序反映了对可靠、高效且检验的检测解决方案的需求，这些解决方案能够保障产品品质并满足严格的法规标准。

根据技术，市场可分为四个细分领域：基于PCR的检测、ELISA、DNA染色和微生物培养。基于PCR的检测凭藉其高灵敏度、快速出结果以及在品管和污染监测工作流程中的广泛应用，占据市场主导地位。 ELISA排名第二，以其强大的抗原抗体检测能力以及适用于高通量筛检和品管流程而闻名。 DNA染色主要用于研究和专业实验室应用，以目视方式检测霉浆菌污染，但与分子方法相比，其灵敏度较低且操作繁琐。微生物培养排名垫底。虽然它是霉浆菌检测的传统黄金标准，但其处理速度慢、需要专业知识且通量低，限制了其在现代对时间要求严格的生产环境中的应用。总体而言，市场优先考虑的是准确性、速度以及与自动化工作流程的整合。

霉浆菌检测市场—区域分析

霉浆菌检测市场呈现明显的区域趋势。北美地区凭藉其强大的生物製药产业、先进的实验室基础设施以及严格的污染控制监管要求，占据了约38-40%的市场份额，并推动了全球需求。美国是北美市场的主要主导力量，因为主要的治疗药物和疫苗生产商已将霉浆菌检测纳入其品管通讯协定。欧洲市场份额位居第二，德国、英国和法国等国的监管协调和生物技术研究的拓展推动了快速检测解决方案的普及。亚太地区是成长最快的市场，这主要得益于中国、印度和日本不断扩大的製药生产以及对自动化检测系统投资的增加。策略发展正在增强区域市场的成长势头，例如生物梅里埃公司于2024年5月与Anabiotek公司合作开发创新的霉浆菌调查方法。主要企业在全球的推广活动也提高了试剂盒和服务的可及性。

霉浆菌检测市场—国家分析

从国家层级来看，美国是霉浆菌检测的领先市场。这主要得益于美国大规模的生物製药产业、严格的监管污染标准以及广泛的研发活动，这些因素共同促成了先进检测解决方案的高普及率。到2024年，北美整体将占据全球近一半的市场份额，其中美国是最大的贡献者。在欧洲，德国、英国和法国等国家也是重要的市场贡献者，这得益于其强大的研究基础设施和生物製药生产中广泛的污染控制倡议。以中国、日本和印度主导的亚太地区正随着药品产量的成长和品管投入的增加而快速扩张。尤其值得一提的是，由于国内生物技术活动的活跃，中国市场预计将实现强劲成长。诸如bioMérieux与Anabiotek于2024年合作改善霉浆菌检测方法等策略合作，将进一步推动各国的能力提升与创新。

目录

第一章霉浆菌检测市场概览

  • 分析范围
  • 市场估算期

第二章执行摘要

  • 市场区隔
  • 竞争考察

第三章霉浆菌检测市场主要趋势

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 未来市场趋势

第四章霉浆菌检测市场：产业分析

  • PEST分析
  • 波特五力分析
  • 市场成长展望：概览
  • 管理体制分析

第五章霉浆菌检测市场：地缘政治紧张局势加剧的影响

  • 新冠疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章霉浆菌检测市场现状

  • 霉浆菌检测市占率分析（2024 年）
  • 主要製造商的细分数据
    • 对现有公司的分析
    • 新兴企业分析

第七章 依产品类型霉浆菌检测市场

  • 概述
    • 细分市场占有率分析：依产品类型
    • 霉浆菌检测试剂盒
    • 试剂和测定
    • 参考标准物质

第八章霉浆菌检测市场（依技术划分）

  • 概述
    • 细分市场占有率分析：依技术划分
    • 基于PCR的检测
    • ELISA
    • DNA染色方法
    • 微生物培养法

第九章霉浆菌检测市场（依检测类型划分）

  • 概述
    • 细分市场占有率分析：依测试类型
    • 定性测试
    • 定量测试

第十章霉浆菌检测市场（依应用领域划分）

  • 概述
    • 细分市场占有率分析：按应用
    • 细胞株检测
    • 疫苗生产试验
    • 生物製药生产
    • 临床诊断

第十一章霉浆菌检测市场（按地区划分）

  • 介绍
  • 北美洲
    • 概述
    • 北美主要製造商
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲主要製造商
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 其他的
  • 亚太地区
    • 概述
    • 亚太地区主要製造商
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 其他的
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 其他的
  • 中东和非洲（MEA）
    • 概述
    • 中东和非洲的主要製造商
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 其他的

第十二章 主要供应商分析－霉浆菌检测产业

  • 竞争对手仪錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Agilent Technologies
    • ATCC
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories
    • Charles River Laboratories
    • Creative Diagnostics
    • Eurofins Scientific
    • Fujifilm Irvine Scientific
    • Hologic
    • InvivoGen
    • Lonza Group
    • Merck KGaA
    • Meridian Bioscience
    • Minerva Biolabs
    • PromoCell
    • QIAGEN
    • Roche Diagnostics
    • Sigma-Aldrich
    • Takara Bio
    • Thermo Fisher Scientific
    • Others

第十三章：分析师的全方位展望

简介目录
Product Code: ANV5963

Mycoplasma Testing Market size was valued at US$ 1,452.54 Million in 2024, expanding at a CAGR of 12.01% from 2025 to 2032.

Mycoplasma testing involves detecting and quantifying Mycoplasma contamination in cell cultures, biologics, and pharmaceutical products to ensure product safety and compliance with regulatory standards. The growing demand for biologics, vaccines, and cell-based therapies is driving the adoption of Mycoplasma testing solutions across research and manufacturing laboratories. Opportunities exist in developing rapid, high-sensitivity assays and automated testing platforms that reduce turnaround times and enhance detection accuracy, which is critical for maintaining quality in large-scale biopharmaceutical production. A prominent trend is the integration of molecular and PCR-based techniques with traditional culture methods to improve reliability while minimizing false negatives. However, the complexity of Mycoplasma detection and variability in test sensitivity pose challenges, limiting adoption in small-scale laboratories and in applications requiring ultra-rapid or high-throughput testing.

Mycoplasma Testing Market- Market Dynamics

Rising demand for contamination control in biopharmaceutical and cell therapy production

The growing adoption of biopharmaceuticals, vaccines, and cell-based therapies is significantly driving the demand for Mycoplasma testing solutions, which play a critical role in ensuring the safety, quality, and regulatory compliance of these products. As manufacturers increasingly scale up production of biologics and therapeutic cell lines, there is a pressing need for rapid and reliable Mycoplasma detection methods to prevent contamination that can compromise product efficacy and patient safety. The trend toward high-throughput and automated testing platforms is further increasing demand, as these solutions enable faster results, consistent accuracy, and integration into modern bio manufacturing workflows. Moreover, the continuous growth in global biologics production, particularly in regions such as North America and Europe, is significantly driving the requirement for sensitive and standardized Mycoplasma testing. For instance, recent data from 2024 indicates that over 75 percent of biopharmaceutical manufacturers perform routine Mycoplasma testing across all cell-based production lines. The expanding use of gene and cell therapies is also intensifying the need for robust contamination monitoring to maintain stringent quality standards.

Mycoplasma Testing Market- Segmentation Analysis:

The Global Mycoplasma Testing Market is segmented on the basis of Product Type, Technology, Test Type, Application, and Region.

The market is segmented into three categories based on product type: Mycoplasma detection kits, reagents & assays, and reference standards. These kits offer rapid, standardized, and validated solutions, reducing time and labor in testing workflows. Reagents & Assays rank second, as they are essential for customizing detection protocols, supporting both manual and automated testing platforms, and enabling higher sensitivity and specificity in molecular and culture-based detection methods. Reference Standards follow, providing critical quality controls and calibration materials to ensure assay accuracy, regulatory compliance, and reproducibility across laboratories. Overall, the market prioritization reflects the need for reliable, efficient, and validated testing solutions that safeguard product quality and meet stringent regulatory standards.

The market is categorized into four segments based on technology: PCR-based testing, ELISA, DNA staining, and microbial culture methods. The PCR-based testing segment leads the market, driven by its high sensitivity, rapid turnaround, and broad adoption in quality control and contamination monitoring workflows. ELISA ranks second, valued for its robust antigen-antibody detection capabilities and applicability in high-throughput screening and quality control processes. DNA Staining follows, used primarily in research and specialized laboratory applications to detect mycoplasma contamination visually, though it is less sensitive and labor-intensive compared to molecular methods. Microbial Culture Methods rank last, as they remain the traditional standard for mycoplasma detection but are slower, require specialized expertise, and have lower throughput, limiting their use in modern, time-sensitive production environments. Overall, prioritization reflects accuracy, speed, and integration with automated workflow.

Mycoplasma Testing Market- Geographical Insights

The Mycoplasma Testing Market shows distinct regional dynamics, with North America leading global demand due to its robust biopharmaceutical industry, advanced laboratory infrastructure, and strict regulatory requirements for contamination control, accounting for about 38-40% of the market share. The United States drives this dominance as major therapeutic and vaccine manufacturers routinely implement mycoplasma testing in quality control protocols. Europe holds the second-largest share, supported by harmonized regulations and expanded biotechnology research in countries such as Germany, the UK, and France, which boosts the adoption of rapid detection solutions. The Asia-Pacific region is the fastest-growing market, propelled by expanding pharmaceutical production in China, India, and Japan and increasing investments in automated testing systems. Strategic developments reinforce regional momentum; for example, bioMerieux partnered with AnaBioTec in May 2024 to advance innovative mycoplasma testing methodologies, and global expansion initiatives by major players are increasing accessibility of kits and services.

Mycoplasma Testing Market- Country Insights

At the country level, the United States is the foremost market for mycoplasma testing, driven by its substantial biopharmaceutical industry, stringent regulatory contamination standards, and extensive R&D activity, which collectively lead to high adoption of advanced testing solutions. North America overall accounted for nearly half of the global market in 2024, with the U.S. as the primary contributor. In Europe, countries such as Germany, the United Kingdom, and France are significant contributors, supported by strong research infrastructure and widespread contamination control initiatives in biologics manufacturing. The Asia-Pacific region, led by China, Japan, and India, is expanding rapidly as pharmaceutical production increases and investment in quality control rises, with China's market projected to grow strongly due to robust domestic biotech activity. Strategic collaborations, such as bioMerieux's 2024 partnership with AnaBioTec to enhance mycoplasma detection methods, further advance country-level capabilities and innovation.

Mycoplasma Testing Market- Competitive Landscape:

The competitive landscape of the Mycoplasma Testing Market is shaped by a mix of established life science firms and specialized diagnostics providers focused on contamination detection solutions. Key players such as Merck KGaA, bioMerieux SA, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Lonza Group Ltd., and Charles River Laboratories International Inc. compete on the basis of test accuracy, speed, automation compatibility, and global distribution networks. Companies are investing in assay development, automation integration, and expanded service offerings to strengthen market positions. Strategic transactions are actively reshaping competition; for instance, bioMerieux's partnership with AnaBioTec in 2024 aims to co-develop enhanced mycoplasma detection technologies, while Thermo Fisher Scientific's acquisition of Qiagen's Cell Culture and Molecular Diagnostics Business (completed in 2023) expanded its infectious disease and contamination testing portfolio, including mycoplasma solutions. Ongoing collaborations with contract research organizations and genomic service providers further extend the reach of testing platforms, supporting broad adoption in biopharmaceutical manufacturing and research environments. Overall, competitive dynamics prioritize innovation, regulatory compliance, and comprehensive testing solutions.

Recent Developments:

In September 2025, Fuse Diagnostics launched its Flip Mycoplasma rapid mycoplasma contamination test across major European countries through a distribution agreement with CliniSciences, enabling ultra-rapid, simple cell culture quality screening without complex equipment.

Agathos Biologics stated in April 2023 that it would provide life science researchers with analytical testing services. Agathos only uses QIAGEN-developed QIAcuity equipment and assays. Additionally, Agathos and QIAGEN have partnered to test and validate mycoplasma and recombinant adeno-associated viral vector (rAAV) assays.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MYCOPLASMA TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Agilent Technologies
  • ATCC
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories
  • Charles River Laboratories
  • Creative Diagnostics
  • Eurofins Scientific
  • Fujifilm Irvine Scientific
  • Hologic
  • InvivoGen
  • Lonza Group
  • Merck KGaA
  • Meridian Bioscience
  • Minerva Biolabs
  • PromoCell
  • QIAGEN
  • Roche Diagnostics
  • Sigma-Aldrich
  • Takara Bio
  • Thermo Fisher Scientific
  • Others

GLOBAL MYCOPLASMA TESTING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Mycoplasma Detection Kits
  • Reagents & Assays
  • Reference Standards

GLOBAL MYCOPLASMA TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • PCR-Based Testing
  • ELISA
  • DNA Staining
  • Microbial Culture Methods

GLOBAL MYCOPLASMA TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Qualitative Testing
  • Quantitative Testing

GLOBAL MYCOPLASMA TESTING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Cell Line Testing
  • Vaccine Production Testing
  • Biopharmaceutical Manufacturing
  • Clinical Diagnostics

GLOBAL MYCOPLASMA TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Mycoplasma Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Mycoplasma Testing Market Snippet by Product Type
    • 2.1.2. Mycoplasma Testing Market Snippet by Technology
    • 2.1.3. Mycoplasma Testing Market Snippet by Test Type
    • 2.1.4. Mycoplasma Testing Market Snippet by Application
    • 2.1.5. Mycoplasma Testing Market Snippet by Country
    • 2.1.6. Mycoplasma Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Mycoplasma Testing Key Market Trends

  • 3.1. Mycoplasma Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Mycoplasma Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Mycoplasma Testing Market Opportunities
  • 3.4. Mycoplasma Testing Market Future Trends

4. Mycoplasma Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Mycoplasma Testing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Mycoplasma Testing Market Landscape

  • 6.1. Mycoplasma Testing Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Mycoplasma Testing Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Mycoplasma Detection Kits
    • 7.1.3. Reagents & Assays
    • 7.1.4. Reference Standards

8. Mycoplasma Testing Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 8.1.2. PCR-Based Testing
    • 8.1.3. ELISA
    • 8.1.4. DNA Staining
    • 8.1.5. Microbial Culture Methods

9. Mycoplasma Testing Market - By Test Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
    • 9.1.2. Qualitative Testing
    • 9.1.3. Quantitative Testing

10. Mycoplasma Testing Market - By Application

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 10.1.2. Cell Line Testing
    • 10.1.3. Vaccine Production Testing
    • 10.1.4. Biopharmaceutical Manufacturing
    • 10.1.5. Clinical Diagnostics

11. Mycoplasma Testing Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Mycoplasma Testing Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Mycoplasma Testing Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Mycoplasma Testing Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Mycoplasma Testing Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Mycoplasma Testing Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Mycoplasma Testing Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Agilent Technologies
    • 12.2.2. ATCC
    • 12.2.3. Becton, Dickinson and Company
    • 12.2.4. Bio-Rad Laboratories
    • 12.2.5. Charles River Laboratories
    • 12.2.6. Creative Diagnostics
    • 12.2.7. Eurofins Scientific
    • 12.2.8. Fujifilm Irvine Scientific
    • 12.2.9. Hologic
    • 12.2.10. InvivoGen
    • 12.2.11. Lonza Group
    • 12.2.12. Merck KGaA
    • 12.2.13. Meridian Bioscience
    • 12.2.14. Minerva Biolabs
    • 12.2.15. PromoCell
    • 12.2.16. QIAGEN
    • 12.2.17. Roche Diagnostics
    • 12.2.18. Sigma-Aldrich
    • 12.2.19. Takara Bio
    • 12.2.20. Thermo Fisher Scientific
    • 12.2.21. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us